Skip to main content

and
  1. No Access

    Article

    Systemic inflammatory mediators and cystic fibrosis genotype

    Morbidity and mortality in cystic fibrosis patients is mainly attributed to pulmonary infection and inflammation. Chemokines play a pivotal role in the inflammatory process. Although genotype-phenotype correla...

    A. Augarten, G. Paret, I. Avneri, H. Akons, M. Aviram in Clinical and Experimental Medicine (2004)

  2. No Access

    Article

    Serum CA 19–9 levels as a diagnostic marker in cystic fibrosis patients with borderline sweat tests

    Patients with normal or borderline sweat tests present a diagnostic challenge. In spite of the availability of genetic analysis and measurement of nasal potential difference, there is still uncertainty in diag...

    A. Augarten, H. Berman, M. Aviram, A. Diver-Habber in Clinical and Experimental Medicine (2003)

  3. No Access

    Article

    Maternal hyperphenylalaninaemia in Israel

    B. E. Cohen, A. Szeinberg, Y. Zarfin, M. Normand in Journal of Inherited Metabolic Disease (1986)

  4. No Access

    Chapter

    Maternal Hyperphenylalaninaemia in Israel

    During the 21 years of national newborn screening for phenylketonuria (PKU) in Israel, originally supported by grants from the NIH, Washington (HEW-WA/CB-Israel-9, 1964–1967) and subsequently taken up by the I...

    B. E. Cohen, A. Szeinberg, Y. Zarfin in Practical Developments in Inherited Metabo… (1986)